FDA REFORM PROSPECTS "VERY GOOD" IN 105th CONGRESS, COMMERCE STAFFER HOLCOMBE SAYS; REFORM ADVOCATES SHOULD AVOID "EXAGGERATION AND HYPERBOLE"
Executive Summary
"The prospects are very good for making responsible, careful, thoughtful changes in the FD&C Act" during the 105th Congress, House Commerce Committee minority staffer Kay Holcombe told the National Association of Pharmaceutical Manufacturers annual meeting Jan. 31 in Naples, Fla.